What is the role of the microbiome in biopharmaceutical development?

The following Q&A is intended to help answer questions about the delisting of the PDL BioPharma, Inc.'s (PDL or the Company) stock and Plan of Dissolution. We have an educational opportunity just for you. In partnership with many other organizations, the BioPharmaceutical Technology Center Institute (BTC Institute) ... We are entering a new era of medicine, where breakthrough science and robust biopharmaceutical R&D are revolutionizing patient care. Advances in genomics ... “Antibiotics transformed modern medicine but overuse and inappropriate use have led to dangerous bacteria developing deadly resistance. Drug discovery must go ... Led by our passion for patients, we ignite innovation in science and in careers. Join us as we transform lives through science. Dec 12, 2022 ... Biopharma has shown growing interest in royalty financing to fund clinical development and drug product launches. The Global Biopharmaceutical CMO Market size is expected to be worth around USD 51.5 Billion by 2032 from USD 18.2 Billion in 2023, growing at a CAGR of 12.6% ... Aug 30, 2022 ... Biopharmaceuticals are a type of drug that is manufactured from biological sources, as opposed to being chemically synthesized. They can be used ... BioPharma has built a full suite of clinical trial solutions from Phase I to BE/BA services to assist our clients' clinical drug development programs. INTRODUCTION ... Both definitions imply the relationship between the physicochemical properties of the drug, the drug's biological fate in the body after its ...